Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,450 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
4

PRIMARY DOCUMENT

Filing date
08 Aug 2022
Reporting date
04 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Aug 2022
Reporting date
04 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
31 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
20 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
11 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T

SC TO-T

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19034

DEFA14A filing

Filing date
21 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19034

DEFA14A filing

Filing date
21 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19034

DEF 14A filing

Filing date
21 Apr 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-T

Filing date
19 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2022
Reporting date
08 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .